(Q38124448)

29 August 2017

0 references

Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings (English)

1 reference

29 August 2017

1 reference

substance use disorder

1 reference

Patrizia Thoma

1

1 reference

PubMed ID

23890122

29 August 2017

Irene Daum

series ordinal

2

1 reference

29 August 2017

25 July 2013

1 reference

Psychiatry and Clinical Neurosciences

29 August 2017

1 reference

29 August 2017

67

1 reference

29 August 2017

6

1 reference

29 August 2017

367-383

1 reference

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

29 August 2017

1 reference

Substance misuse at presentation to an early psychosis program

21 January 2018

1 reference

Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome.

21 January 2018

1 reference

Comorbid substance use and age at onset of schizophrenia

21 January 2018

1 reference

Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder

21 January 2018

1 reference

Dual diagnosis: a review of etiological theories

21 January 2018

1 reference

A meta-analysis of negative symptoms in dual diagnosis schizophrenia

21 January 2018

1 reference

A national study of violent behavior in persons with schizophrenia

21 January 2018

1 reference

Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study

21 January 2018

1 reference

Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders

21 January 2018

1 reference

Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia

21 January 2018

1 reference

Associations between past alcohol, cannabis, and cocaine use and current schizotypy among first-degree relatives of patients with schizophrenia and non-psychiatric controls.

21 January 2018

1 reference

Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study

21 January 2018

1 reference

The impact of substance use on brain structure in people at high risk of developing schizophrenia

21 January 2018

1 reference

Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia.

21 January 2018

1 reference

A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors

21 January 2018

1 reference

Schizophrenia and smoking: an epidemiological survey in a state hospital

21 January 2018

1 reference

Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia

21 January 2018

1 reference

Fewer but heavier caffeine consumers in schizophrenia: a case-control study

21 January 2018

1 reference

Prevalence of alcohol use disorders in schizophrenia--a systematic review and meta-analysis

21 January 2018

1 reference

Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis

21 January 2018

1 reference

Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models

21 January 2018

1 reference

The environment and schizophrenia: the role of cannabis use.

21 January 2018

1 reference

The environment and schizophrenia

21 January 2018

1 reference

An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results

21 January 2018

1 reference

Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia

21 January 2018

1 reference

A neurobiological basis for substance abuse comorbidity in schizophrenia

21 January 2018

1 reference

Substance use and abuse in first-episode psychosis: prevalence before and after early intervention

21 January 2018

1 reference

Patterns of current and lifetime substance use in schizophrenia.

21 January 2018

1 reference

Impulsivity and sensation seeking in alcohol abusing patients with schizophrenia

21 January 2018

1 reference

Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia.

21 January 2018

1 reference

Reasons for substance use in schizophrenia.

21 January 2018

1 reference

Substance use disorders in schizophrenia--clinical implications of comorbidity

21 January 2018

1 reference

Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems

21 January 2018

1 reference

Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory

21 January 2018

1 reference

Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress

21 January 2018

1 reference

Substance use disorders in schizophrenia: review, integration, and a proposed model

21 January 2018

1 reference

Schizophrenia: diathesis-stress revisited

21 January 2018

1 reference

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications

21 January 2018

1 reference

Nicotine use in schizophrenia: the self medication hypotheses

21 January 2018

1 reference

Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

21 January 2018

1 reference

Dysfunction of ventral striatal reward prediction in schizophrenia

21 January 2018

1 reference

Impairment of probabilistic reward-based learning in schizophrenia.

21 January 2018

1 reference

The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia

21 January 2018

1 reference

Cortical-striatal integration of cocaine history and prefrontal dysfunction in animal modeling of dual diagnosis

21 January 2018

1 reference

Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders.

21 January 2018

1 reference

Molecular mechanisms of schizophrenia

21 January 2018

1 reference

The neural circuitry of reward and its relevance to psychiatric disorders

21 January 2018

1 reference

Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms

21 January 2018

1 reference

Use of caffeine and nicotine in people with schizophrenia

21 January 2018

1 reference

Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia

21 January 2018

1 reference

Are we dependent upon coffee and caffeine? A review on human and animal data

21 January 2018

1 reference

The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?

21 January 2018

1 reference

Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia

21 January 2018

1 reference

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

21 January 2018

1 reference

GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.

21 January 2018

1 reference

Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand

21 January 2018

1 reference

Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis.

21 January 2018

1 reference

Cannabis induced dopamine release: an in-vivo SPECT study

21 January 2018

1 reference

Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction

21 January 2018

1 reference

Schizophrenia, substance use, and brain morphology.

21 January 2018

1 reference

Alcohol use disorders contribute to hippocampal and subcortical shape differences in schizophrenia.

21 January 2018

1 reference

Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia

21 January 2018

1 reference

Compounded brain volume deficits in schizophrenia-alcoholism comorbidity

21 January 2018

1 reference

21 January 2018

1 reference

Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia.

21 January 2018

1 reference

The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?

21 January 2018

1 reference

Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults

21 January 2018

1 reference

Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats.

21 January 2018

1 reference

Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients

21 January 2018

1 reference

Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood.

21 January 2018

1 reference

Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men.

21 January 2018

1 reference

Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects.

21 January 2018

1 reference

Effects of nicotine on hippocampal and cingulate activity during smooth pursuit eye movement in schizophrenia

21 January 2018

1 reference

Nicotine effects on brain function and functional connectivity in schizophrenia

21 January 2018

1 reference

Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia

21 January 2018

1 reference

Smoking status as a potential confound in the BOLD response of patients with schizophrenia.

21 January 2018

1 reference

Chronic smoking and the BOLD response to a visual activation task and a breath hold task in patients with schizophrenia and healthy controls

21 January 2018

1 reference

Brain imaging and the effects of caffeine and nicotine

21 January 2018

1 reference

Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study

21 January 2018

1 reference

Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.

21 January 2018

1 reference

Cognition in schizophrenia: impairments, determinants, and functional importance

21 January 2018

1 reference

Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions

21 January 2018

1 reference

It could be habit forming: drugs of abuse and striatal synaptic plasticity.

21 January 2018

1 reference

Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.

21 January 2018

1 reference

CANTAB explicit memory is less impaired in addicted schizophrenia patients.

21 January 2018

1 reference

Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients.

21 January 2018

1 reference

Basal ganglia-thalamocortical circuitry disruptions in schizophrenia during delayed response tasks.

21 January 2018

1 reference

Neurocognitive insights into substance abuse

21 January 2018

1 reference

Frontal cortex as the central executive of working memory: time to revise our view.

21 January 2018

1 reference

The prefrontal cortex: insights from functional neuroimaging using cognitive activation tasks

21 January 2018

1 reference

Response inhibition and cognitive flexibility in schizophrenia with and without comorbid substance use disorder

21 January 2018

1 reference

Working memory and multi-tasking in paranoid schizophrenia with and without comorbid substance use disorder.

21 January 2018

1 reference

Schizophrenia, sensory gating, and nicotinic receptors.

21 January 2018

1 reference

Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients

21 January 2018

1 reference

The effects of nicotine on specific eye tracking measures in schizophrenia

21 January 2018

1 reference

Nicotine reduces antisaccade errors in task impaired schizophrenic subjects

21 January 2018

1 reference

Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status

21 January 2018

1 reference

Why do patients with schizophrenia smoke?

21 January 2018

1 reference

Risk/reward decision-making in schizophrenia: a preliminary examination of the influence of tobacco smoking and relationship to Wisconsin Card Sorting Task performance

21 January 2018

1 reference

Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia

21 January 2018

1 reference

Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia

21 January 2018

1 reference

Effects of caffeine on sleep and cognition

21 January 2018

1 reference

Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients

21 January 2018

1 reference

Screening for cognitive functioning in psychiatric outpatients with schizophrenia, alcohol dependence, and dual diagnosis.

21 January 2018

1 reference

Cognitive impairment in dual diagnosis inpatients with schizophrenia and alcohol use disorder.

21 January 2018

1 reference

Neuropsychological and sensory gating deficits related to remote alcohol abuse history in schizophrenia

21 January 2018

1 reference

Frontal lobe changes in alcoholism: a review of the literature

21 January 2018

1 reference

Reduced hippocampal volume among adolescents with alcohol use disorders without psychiatric comorbidity

21 January 2018

1 reference

Differential contributions of prefrontal and hippocampal dopamine D(1) and D(2) receptors in human cognitive functions

21 January 2018

1 reference

Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia

21 January 2018

1 reference

Cannabis use and cognition in schizophrenia

21 January 2018

1 reference

The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues

21 January 2018

1 reference

Cannabis use disorders in schizophrenia: effects on cognition and symptoms

21 January 2018

1 reference

The role of cannabis in cognitive functioning of patients with schizophrenia.

21 January 2018

1 reference

Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.

21 January 2018

1 reference

The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis

21 January 2018

1 reference

The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample

21 January 2018

1 reference

Cannabis use and cognitive functioning in first-episode schizophrenia patients.

21 January 2018

1 reference

Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics.

21 January 2018

1 reference

Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients

21 January 2018

1 reference

Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenic patients.

21 January 2018

1 reference

Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients

21 January 2018

1 reference

Cognitive disparity in schizophrenics with and without cocaine dependency

21 January 2018

1 reference

Neurocognitive characteristics of individuals with schizophrenia and cocaine dependence: comparison of currently dependent and remitted groups

21 January 2018

1 reference

Predictors of smoking severity in patients with schizophrenia and alcohol use disorders

21 January 2018

1 reference

Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.

21 January 2018

1 reference

Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations

21 January 2018

1 reference

Treating comorbid substance use disorders in schizophrenia

21 January 2018

1 reference

Exploring depression in schizophrenia

21 January 2018

1 reference

Anxiety and substance use comorbidity among inpatients with schizophrenia

21 January 2018

1 reference

Traumatic life events and PTSD among women with substance use disorders and schizophrenia.

21 January 2018

1 reference

Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia

21 January 2018

1 reference

Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS)

21 January 2018

1 reference

Cerebellar volumes in men with schizophrenia and alcohol dependence

21 January 2018

1 reference

Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients

21 January 2018

1 reference

Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PCN.12072

1 reference

29 August 2017

1 reference

PubMed ID

23890122